Showing results (201-210 of 398) with videos related to
Sort By:
Pageof 40
Cancer Research and Treatment|January 22, 2011
Oxaliplatin-induced chronic peripheral neurotoxicity: a prospective analysis in patients with colorectal cancerKyung Kee Baek, Jeeyun Lee, Se Hoon Park, et al.Molecular Biosystems|October 11, 2016
Glycomic profiling of targeted serum haptoglobin for gastric cancer using nano LC/MS and LC/MS/MSSung Hyeon Lee, Seunghyup Jeong, Jua Lee, et al.Journal of Cachexia, Sarcopenia and Muscle|March 7, 2025
Paradoxical Effect of Myosteatosis on the Immune Checkpoint Inhibitor Response in Metastatic Renal Cell CarcinomaJiwoong Yu, Hyeonju Ahn, Kyung Yeon Han, et al.JCO Precision Oncology|September 11, 2020
Prospective Feasibility Study for Using Cell-Free Circulating Tumor DNA-Guided Therapy in Refractory Metastatic Solid Cancers: An Interim AnalysisSeung Tae Kim, Kimberly C Banks, Se-Hoon Lee, et al.International Journal of Hematology|March 10, 2004
Tuberculosis in hematopoietic stem cell transplant recipients in KoreaJeeyun Lee, Mark H Lee, Won Seog Kim, et al.Journal of Nanoscience and Nanotechnology|February 17, 2018
Development of a Spoke Type Torque Sensor Using Painting Carbon Nanotube Strain SensorsSung Yong Kim, Se Hoon Park, Baek Gyu Choi, et al.Cancer Research and Treatment|May 27, 2017
Pazopanib for the Treatment of Non-clear Cell Renal Cell Carcinoma: A Single-Arm, Open-Label, Multicenter, Phase II StudyKi Sun Jung, Su Jin Lee, Se Hoon Park, et al.BMC Cancer|October 28, 2010
Retrospective analyses of cisplatin-based doublet combination chemotherapy in patients with advanced gastric cancerDo Hyoung Lim, Se Hoon Park, Keon Woo Park, et al.Cancer Chemotherapy and Pharmacology|October 27, 2017
A non-randomized, open-label, single-arm, Phase 2 study of emibetuzumab in Asian patients with MET diagnostic positive, advanced gastric cancerDaisuke Sakai, Hyun Cheol Chung, Do-Youn Oh, et al.Journal of Oncology|May 16, 2020
Detection of Fusion Genes Using a Targeted RNA Sequencing Panel in Gastrointestinal and Rare CancersSu Jin Lee, Jung Yong Hong, Kyung Kim, et al.Pageof 40